Q1: What area of law does Pegram v. Herdrich primarily address?
ERISA
Q2: What was the central legal issue in Pegram v. Herdrich?
Are HMO physicians and organizations acting as ERISA fiduciaries when they make mixed eligibility-and-treatment decisions influenced by internal cost-containment incentives, such that patients may sue under ERISA for breach of fiduciary duty?
Q3: What rule did the court apply?
Under ERISA, a person is a fiduciary only to the extent they exercise discretionary authority or control over plan management or assets, or have discretionary responsibility in the administration of the plan (29 U.S.C. § 1002(21)(A)). Medical judgments by HMO physicians, including mixed eligibility-and-treatment decisions at the point of care—even when influenced by cost-containment incentives—are not fiduciary acts under ERISA and cannot support ERISA breach-of-fiduciary-duty claims.
Q4: What was the court's holding?
No. The Supreme Court held unanimously that HMO physicians' mixed eligibility-and-treatment decisions are not ERISA fiduciary acts. Consequently, ERISA does not provide a cause of action for breach of fiduciary duty based on those decisions or the incentive structures that influence them. The Court reversed the Seventh Circuit.
Q5: Why is Pegram v. Herdrich significant?
Pegram v. Herdrich sets a key boundary in ERISA litigation by clarifying that HMO physicians' mixed eligibility-and-treatment decisions are not fiduciary acts. The decision preserves space for state malpractice and health-care regulation to govern medical negligence and ensures ERISA fiduciary duties remain tethered to plan management and administration. It also validates the use of cost-containment incentives in HMOs, absent separate wrongdoing such as misrepresentation or improper plan administration. For students, Pegram is foundational for understanding ERISA's fiduciary framework, the treatment/eligibility distinction, and how federal ERISA claims interact with state malpractice law and later ERISA preemption jurisprudence.